Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
AstraZeneca
McKinsey
Mallinckrodt
McKesson

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

Novitium Pharma Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?

NOVITIUM PHARMA has sixteen approved drugs.

There is one tentative approval on NOVITIUM PHARMA drugs.

Summary for Novitium Pharma
US Patents:0
Tradenames:16
Ingredients:15
NDAs:16
Patent Litigation for Novitium Pharma: See patent lawsuits for Novitium Pharma

Drugs and US Patents for Novitium Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novitium Pharma PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 210971-002 Oct 3, 2018 AB RX No No   Start Trial   Start Trial
Novitium Pharma CLOTRIMAZOLE clotrimazole SOLUTION;TOPICAL 209815-001 Feb 14, 2019 AT RX No No   Start Trial   Start Trial
Novitium Pharma LEVOCARNITINE levocarnitine SOLUTION;ORAL 211676-001 Aug 14, 2019 AA RX No No   Start Trial   Start Trial
Novitium Pharma PREDNISONE prednisone TABLET;ORAL 211575-003 Nov 15, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Merck
McKinsey
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.